Iterum Therapeutics PLC (ITRMF) Stock Price & News

All values in USD	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Revenue	-	-	-	390.00K
Cost of goods sold	254.00K	342.00K	345.00K	20.00K
Cost of revenue	254.00K	342.00K	345.00K	20.00K
Research and development expenses	1.30M	591.00K	1.00M	1.26M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.12M	2.78M	4.18M	6.49M
Operating expense	3.42M	3.37M	5.18M	8.10M
Total operating expenses	3.67M	3.71M	5.53M	8.12M
Operating income	-3.67M	-3.71M	-5.53M	-7.73M
Other non operating income	-2.01M	-587.00K	-605.00K	-675.00K
EBT including unusual items	-6.56M	-4.83M	-6.45M	-8.85M
EBT excluding unusual items	-6.56M	-4.83M	-6.45M	-8.85M
Income tax expense	25.00K	60.00K	59.00K	132.00K
Effective tax rate	-0.38%	-1.24%	-0.91%	-1.49%
Other operating expenses	-	-	-	-
Net income	-6.58M	-4.89M	-6.51M	-8.98M
Net profit margin	-	-	-	-2,302.31%
Earnings per share	-0.12	-	-	-
Interest and investment income	-	152.00K	-	121.00K
Interest expense	-874.00K	-686.00K	-316.00K	-562.00K
Net interest expenses	-874.00K	-534.00K	-316.00K	-441.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-3.41M	-3.36M	-5.18M	-7.38M
Gain or loss from assets sale	-	-	-	-

Finance